Walk MS is coming to Soldier Field April 27. Help fight multiple sclerosis. Register now for Walk MS at Soldier Field on ...

No added benefits in slowing MS disability progression were found in a study that increased Ocrevus dosing to 2-3 times the ...

Treatment with tolebrutinib led to greater confirmed disability improvement at 6 months compared with placebo in patients ...

San Diego to raise awareness and funds to find a cure for multiple sclerosis. Hosted by the National Multiple Sclerosis ...

Swiss pharma giant Roche RHHBY faced a setback in its efforts to develop a higher dose of multiple sclerosis drug Ocrevus ...

A local naval officer is fearlessly facing his multiple sclerosis diagnosis, using his creativity and entrepreneurial skills ...

Roche Holdings AG (OTC:RHHBY) on Wednesday announced data from MUSETTE Phase 3 trial of a high dose of Ocrevus (ocrelizumab) ...

MS patients may receive less frequent rituximab infusions without increasing their chances of relapse or disease progression, ...

A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...

The Swiss pharmaceutical giant said Wednesday that the trial compared a high dose of Ocrevus intravenous infusion to the currently approved Ocrevus IV 600 mg dose in people with relapsing multiple ...

Biomarker testing also extends beyond cancer care. The science is being used in the treatment of other diseases including ...

Roche said on Wednesday that a trial testing higher doses of its multiple sclerosis drug Ocrevus did not show an efficacy ...